Clinical Trial Update: A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial evaluating dose response and tolerability of the investigational drug IB-001 in healthy adults and individuals with chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• IB-001 (IB-001)

Snippet

Sponsor: IntegerBio | Conditions: Chronic Hepatitis B Virus Infection | Phase 1 | Status: RECRUITING